UNITY Biotechnology Inc banner

UNITY Biotechnology Inc
NASDAQ:UBX

Watchlist Manager
UNITY Biotechnology Inc Logo
UNITY Biotechnology Inc
NASDAQ:UBX
Watchlist
Price: 0.16 USD -20.04% Market Closed
Market Cap: $960k

During the last 3 months UNITY Biotechnology Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Apr 2, 2025 by Nguyen Alexander Hieu , who sold 18.4k USD worth of UBX shares.

Last Transactions:
Sullivan Lynne Marie
$-22.5k
Nguyen Alexander Hieu
$-18.4k
Ghosh Anirvan
$-99.7k
Nguyen Alexander Hieu
$-2.3k
Sullivan Lynne Marie
$-341.2
Nguyen Alexander Hieu
$-365.7
Ghosh Anirvan
$-1.4k
Sullivan Lynne Marie
$-175.4
Nguyen Alexander Hieu
$-192.2
Ghosh Anirvan
$-557.3
Sullivan Lynne Marie
$-212.7
Ghosh Anirvan
$-924.1
Nguyen Alexander Hieu
$-235.6
Nguyen Alexander Hieu
$-109.2
Ghosh Anirvan
$-1.7k
Sullivan Lynne Marie
$-453.6
Ghosh Anirvan
$-934.7
Ghosh Anirvan
$-1.2k
Ghosh Anirvan
$-2k
Ghosh Anirvan
$-1.1k
Ghosh Anirvan
$-1.9k
Ghosh Anirvan
$-3.1k
Ghosh Anirvan
$-1.7k
Ghosh Anirvan
$-2.9k
Ghosh Anirvan
$-4.1k
Ghosh Anirvan
$-1.3k
Ghosh Anirvan
$-2.2k
Ghosh Anirvan
$-3.3k
Dananberg Jamie
$-714
Dananberg Jamie
$-4k
Ghosh Anirvan
$-4.8k
Dananberg Jamie
$-4.2k
View All Transactions

During the last 3 months UNITY Biotechnology Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Apr 2, 2025 by Nguyen Alexander Hieu , who sold 18.4k USD worth of UBX shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

UNITY Biotechnology Inc
Insider Trading Chart

UNITY Biotechnology Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

UNITY Biotechnology Inc
Last Insider Transactions

Global
Insiders Monitor

UNITY Biotechnology Inc
Glance View

Market Cap
960k USD
Industry
Biotechnology

Unity Biotechnology, Inc. operates as a biotechnology company. The company is headquartered in Brisbane California, California and currently employs 65 full-time employees. The company went IPO on 2018-05-03. The firm is engaged in developing a portfolio of programs targeting specific biological mechanisms implicated in diseases of aging. The firm is focused on creating senolytic medicines to selectively eliminate senescent cells and thereby treat diseases of aging, such as ophthalmologic diseases, with the opportunity to explore neurology and other therapeutic areas. The firm's product includes UBX1325, UBX2089 and UBX2050. UBX1325 is an advanced lead drug candidate for age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), and diabetic retinopathy (DR). UBX2089, an α-Klotho hormone drug candidate, is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications. UBX2050 is investigating fully human anti-Tie2 agonist monoclonal antibody.

UBX Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett